Brian H. Kushner

9.6k total citations
186 papers, 6.7k citations indexed

About

Brian H. Kushner is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Brian H. Kushner has authored 186 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Neurology, 66 papers in Molecular Biology and 50 papers in Oncology. Recurrent topics in Brian H. Kushner's work include Neuroblastoma Research and Treatments (165 papers), Cancer therapeutics and mechanisms (53 papers) and Cancer, Hypoxia, and Metabolism (49 papers). Brian H. Kushner is often cited by papers focused on Neuroblastoma Research and Treatments (165 papers), Cancer therapeutics and mechanisms (53 papers) and Cancer, Hypoxia, and Metabolism (49 papers). Brian H. Kushner collaborates with scholars based in United States, Spain and Canada. Brian H. Kushner's co-authors include Nai‐Kong V. Cheung, Kim Kramer, Shakeel Modak, Michael P. LaQuaglia, Irene Y. Cheung, William L. Gerald, Glenn Heller, Steven M. Larson, Suzanne L. Wolden and Paul A. Meyers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Brian H. Kushner

180 papers receiving 6.6k citations

Peers

Countries citing papers authored by Brian H. Kushner

Since Specialization

Citations

This map shows the geographic impact of Brian H. Kushner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian H. Kushner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian H. Kushner more than expected).

Fields of papers citing papers by Brian H. Kushner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian H. Kushner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian H. Kushner. The network helps show where Brian H. Kushner may publish in the future.

Co-authorship network of co-authors of Brian H. Kushner

This figure shows the co-authorship network connecting the top 25 collaborators of Brian H. Kushner. A scholar is included among the top collaborators of Brian H. Kushner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian H. Kushner. Brian H. Kushner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase II Trial of Naxitamab plus Stepped-up Dosing of GM-CSF for Patients with High-Risk Neuroblastoma in First Complete Remission 2025 ·Clinical Cancer Research ·Brian H. Kushner, Shakeel Modak, Audrey Mauguen, Ellen M. Basu, Kim Kramer, Stephen S. Roberts, Irene Y. Cheung, Nai‐Kong V. Cheung	1
2	Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastoma. 2024 ·Journal of Clinical Oncology ·Jaume Mora, Godfrey Chi Fung Chan, Daniel A. Morgenstern, Loredana Amoroso, Karsten Nysom, Joerg Faber, Arthur Wingerter, (unknown), (unknown), James Eldridge, Karen Tornøe, Maria Düring, Brian H. Kushner	2
3	Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results from a Prospective Clinical Trial 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Christina Jackson, Shakeel Modak, Michael P. LaQuaglia, Brian H. Kushner, J. Ted Gerstle, Ellen M. Basu, Nai‐Kong V. Cheung, (unknown), Suzanne L. Wolden	0
4	N9: Pilot study of novel shortened induction for high-risk neuroblastoma. 2024 ·Journal of Clinical Oncology ·Brian H. Kushner, Audrey Mauguen, Ellen M. Basu, (unknown), J. Ted Gerstle, Kim Kramer, Shakeel Modak	0
5	Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults 2023 ·JCO Precision Oncology ·(unknown), Brian H. Kushner, Stephen S. Roberts, (unknown), Kim Kramer, Shakeel Modak	4
6	129P Naxitamab efficacy in patients with refractory/relapsed high-risk neuroblastoma and bone metastases as assessed by Curie score 2023 ·Immuno-Oncology Technology ·Brian H. Kushner, Jaume Mora, Gcf Chan, Daniel A. Morgenstern, Loredana Amoroso, (unknown), Joerg Faber, Arthur Wingerter, (unknown), (unknown), (unknown), Karen Tornøe	1
7	Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN‐amplified neuroblastoma 2021 ·Pediatric Blood & Cancer ·(unknown), Brian H. Kushner, Shakeel Modak, Ellen M. Basu, Elyssa Rubin, Gunes Gundem, Elli Papaemmanuil, Stephen S. Roberts	8
8	963MO Naxitamab for the treatment of refractory/relapsed high-risk neuroblastoma (HR NB): Updated efficacy and safety data from the international, multicenter phase II trial 201 2021 ·Annals of Oncology ·Jaume Mora, Misty D. Bear, Gcf Chan, Daniel A. Morgenstern, Karsten Nysom, Karen Tornøe, Nedjad Losic, Brian H. Kushner	4
9	Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study 2018 ·OncoImmunology ·Shakeel Modak, Jean-Benoît Le Luduec, Irene Y. Cheung, Debra A. Goldman, Irina Ostrovnaya, Ekaterina Doubrovina, Ellen M. Basu, Brian H. Kushner, Kim Kramer, Stephen S. Roberts, Richard J. O’Reilly, Nai‐Kong V. Cheung, Katharine C. Hsu	70
10	Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival 2017 ·OncoImmunology ·Irene Y. Cheung, Brian H. Kushner, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts, Nai‐Kong V. Cheung	28
11	Plerixafor plus granulocyte‐colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma 2011 ·Pediatric Blood & Cancer ·Shakeel Modak, Irene Y. Cheung, Brian H. Kushner, Kim Kramer, Lilian Reich, Nai‐Kong V. Cheung	25
12	Hyperfractionated Low-Dose (21 Gy) Radiotherapy for Cranial Skeletal Metastases in Patients With High-Risk Neuroblastoma 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Brian H. Kushner, Nai‐Kong V. Cheung, Christopher A. Barker, Kim Kramer, Shakeel Modak, (unknown), Suzanne L. Wolden	9
13	Brain‐sparing radiotherapy for neuroblastoma skull metastases 2007 ·Pediatric Blood & Cancer ·Suzanne L. Wolden, Christopher A. Barker, Brian H. Kushner, (unknown), (unknown), Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung	10
14	Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system 2006 ·Bone Marrow Transplantation ·Brian H. Kushner, Kim Kramer, Shakeel Modak, Nancy A. Kernan, Lilian Reich, (unknown), (unknown)	27
15	Radically Different Treatment Recommendations for Newly Diagnosed Neuroblastoma: Pitfalls in Assessment of Risk 2003 ·Journal of Pediatric Hematology/Oncology ·Brian H. Kushner, Michael P. LaQuaglia, Kim Kramer, Nai‐Kong V. Cheung	15
16	Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive? 1997 ·Journal of Clinical Oncology ·N K Cheung, Glenn Heller, Brian H. Kushner, (unknown), Irene Y. Cheung	63
17	Advanced sensing, modelling, and control of materials processing 1992 ·E. F. Matthys, Brian H. Kushner	11
18	131I-3F8: clinical validation of imaging studies and therapeutic applications. 1991 ·PubMed ·Nai‐Kong V. Cheung, (unknown), (unknown), Michael P. LaQuaglia, (unknown), Brian H. Kushner, Steven M. Larson	3
19	High-dose melphalan with 6-hydroxydopamine–purged autologous bone marrow transplantation for poor-risk neuroblastoma 1991 ·Cancer ·Brian H. Kushner, (unknown), Richard J. O’Reilly, (unknown), (unknown), Philip R. Exelby	18
20	Monozygotic siblings discordant for neuroblastoma: Etiologic implications 1985 ·The Journal of Pediatrics ·Brian H. Kushner, Lawrence Helson	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact